Tumor β-1,4-Galactosyltransferase IV Overexpression Is Closely Associated with Colorectal Cancer Metastasis and Poor Prognosis

Purpose: To elucidate the significance of β-1,4-galactosyltransferase IV (β-1,4-GT-IV) in the clinical presentation and prognostication of colorectal cancer. Experimental Design: Tissue lysates from paired tumor and nontumor tissues of a colon cancer patient were labeled separately with fluorescent dyes Cy5 and Cy3 for two-dimensional difference in-gel electrophoresis. Subsequent matrix-assisted laser desorption/ionization time-of-flight mass spectrometry and immunoblot analyses identified a down-regulated level of β-1,4-GT-IV in the tumor tissue. In the follow-up study, paired tissue lysates were obtained from 100 colorectal cancer patients with immunoblot analyses done to compare the levels of β-1,4-GT-IV expression in these patients. Results: Of 100 colorectal patients studied, 48% had down-regulated expression of β-1,4-GT-IV in the tumor tissue but 28% of patients exhibited elevated β-1,4-GT-IV levels. Increased β-1,4-GT-IV in the tumor tissue was significantly coexistent with raised serum level of CA-199 and the presence of tumor metastasis (P = 0.006 and P < 0.001, respectively) but was independent of age and gender of patient, tumor site, tumor size, serum level of carcinoembryonic antigen, grade of tumor cell differentiation, and depth of tumor invasion. The results of logistic regression analyses suggested that tumor β-1,4-GT-IV overexpression and tumor invasion, but not other patient variables such as tumor size and serum levels of carcinoembryonic antigen and CA19-9, were significantly correlated with the occurrence of metastases (P < 0.05). In a multivariate regression analysis, the patient group with tumor β-1,4-GT-IV overexpression strongly predicted for tumor metastasis (odds ratio, 10.009; 95% confidence interval, 2.992-33.484; P < 0.001). Likewise, tumor β-1,4-GT-IV overexpression was significantly associated with poor overall survival (P < 0.01). By Cox regression analysis, this association remained significant even after adjustment for tumor metastasis (P = 0.048). Conclusion: Increased β-1,4-GT-IV expression in tumor tissue was strongly associated with tumor metastases and poor prognosis in colorectal cancer.

[1]  S. Evans,et al.  Altering the expression of cell surface beta 1,4-galactosyltransferase modulates cell growth. , 1995, Experimental cell research.

[2]  Y. Iwakura,et al.  Growth retardation and early death of β‐1, 4‐galactosyltransferase knockout mice with augmented proliferation and abnormal differentiation of epithelial cells , 1997, The EMBO journal.

[3]  D. Hanahan,et al.  The Hallmarks of Cancer , 2000, Cell.

[4]  Y. Hirabayashi,et al.  Immunohistochemical demonstration of glycoconjugates bearing the type 2 chain-backbone structure in human fetal, normal and neoplastic gastrointestinal tract , 1992, Histochemistry.

[5]  M. Fukuda Possible roles of tumor-associated carbohydrate antigens. , 1996, Cancer research.

[6]  Ruurd van der Zee,et al.  Prediction of sequential antigenic regions in proteins , 1985, FEBS letters.

[7]  Yi-Chen Lin,et al.  Tumor-associated macrophages: the double-edged sword in cancer progression. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[8]  Shou-Dong Lee,et al.  A G-Quadruplex Ligand 3,3′-Diethyloxadicarbocyanine Iodide Induces Mitochondrion-Mediated Apoptosis But Not Decrease of Telomerase Activity in Nasopharyngeal Carcinoma NPC-TW01 Cells , 2004, Pharmaceutical Research.

[9]  B. Vogelstein,et al.  A genetic model for colorectal tumorigenesis , 1990, Cell.

[10]  S. Hakomori Tumor malignancy defined by aberrant glycosylation and sphingo(glyco)lipid metabolism. , 1996, Cancer research.

[11]  S. Nozawa,et al.  Alteration in the metastatic potential of ovarian cancer cells by transfection of the antisense gene of beta-1,4-galactosyltransferase. , 2003, Oncology reports.

[12]  Norbert Gretz,et al.  Identification of metastasis-associated genes in prostate cancer by genetic profiling of human prostate cancer cell lines. , 2005, Anticancer research.

[13]  M. Matsumoto,et al.  Detection of patients with cancer by monoclonal antibody directed to lactoneotetraosylceramide (paragloboside). , 1988, Cancer research.

[14]  Robert A. Weinberg,et al.  Metastasis genes: A progression puzzle , 2002, Nature.

[15]  S. Evans,et al.  Dominant negative mutation in cell surface beta 1,4- galactosyltransferase inhibits cell-cell and cell-matrix interactions , 1993, The Journal of cell biology.

[16]  C. Chi,et al.  Elevated level of spindle checkprotein MAD2 correlates with cellular mitotic arrest, but not with aneuploidy and clinicopathological characteristics in gastric cancer. , 2004, World journal of gastroenterology.

[17]  H. Clausen,et al.  Identification and characterization of large galactosyltransferase gene families: galactosyltransferases for all functions. , 1999, Biochimica et biophysica acta.

[18]  J. Pevsner,et al.  The expanding β4-galactosyltransferase gene family: messages from the databanks , 1998 .

[19]  Chung-Pin Li,et al.  Novel rapid tissue lysis method to evaluate cancer proteins: correlation between elevated Bcl-X(L) expression and colorectal cancer cell proliferation. , 2005, World journal of gastroenterology.

[20]  M. Humphreys-Beher,et al.  Alpha-lactalbumin acts as a bimodal regulator of rat parotid acinar cell growth. , 1987, Biochemical and biophysical research communications.

[21]  R. Marchase,et al.  Isoproterenol-mediated parotid gland hypertrophy is inhibited by effectors of 4 beta-galactosyltransferase. , 1987, The Journal of biological chemistry.

[22]  M. Fukuda,et al.  Expression of N-acetyllactosamine and β1,4-Galactosyltransferase (β4GalT-I) During Adenoma-Carcinoma Sequence in the Human Colorectum , 1999, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[23]  S. Evans,et al.  Evidence for a molecular distinction between Golgi and cell surface forms of beta 1,4-galactosyltransferase. , 1991, The Journal of biological chemistry.

[24]  J. Lowe,et al.  Glycan-dependent leukocyte adhesion and recruitment in inflammation. , 2003, Current opinion in cell biology.

[25]  T. Sato,et al.  Beta-1,4-galactosylation of N-glycans is a complex process. , 1999, Biochimica et biophysica acta.

[26]  E. Petricoin,et al.  Clinical proteomics: translating benchside promise into bedside reality , 2002, Nature Reviews Drug Discovery.

[27]  D. Kessel,et al.  Glycosyltransferase levels in tumors metastatic to liver and in uninvolved liver tissue. , 1977, Journal of the National Cancer Institute.

[28]  C. Bertozzi,et al.  The selectins and their ligands. , 1994, Current opinion in cell biology.

[29]  René Bernards,et al.  A progression puzzle. , 2002, Nature.

[30]  O. H. Lowry,et al.  Protein measurement with the Folin phenol reagent. , 1951, The Journal of biological chemistry.

[31]  B. Shur Cell surface beta 1,4 galactosyltransferase: twenty years later. , 1991, Glycobiology.

[32]  I. Fidler,et al.  Metastasis results from preexisting variant cells within a malignant tumor. , 1977, Science.